Robert L. Ferrara
Known title: DirectorCIK: 0001792987
Robert L. Ferrara's purchase track record
How the stock did after each of Robert L. Ferrara's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
5
of 5 since November 23, 2022
Stock higher 6 months later
0%
3 months: 60%
Median 6-month return
-30.6%
3 months: +5.7%
Beat the S&P 500
0%
median -42.0% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/10/2025 | PHIO | $6K | -1.2% | -53.4% | +13.3% |
| 5/20/2025 | PHIO | $5K | +9.8% | -30.6% | +11.4% |
| 6/14/2023 | PHIO | $6K | -40.3% | -75.2% | +7.6% |
| 12/2/2022 | PHIO | $2K | +25.9% | -29.9% | +5.2% |
| 11/23/2022 | PHIO | $820 | +5.7% | -13.8% | +2.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| PHIO | ▲ Buy | Grant | 23,000 | $0 | 9/11/2025 | View on chart |
| PHIO | ▲ Buy | Open Market | 2,500 | $6K | 6/10/2025 | View on chart |
| PHIO | ▲ Buy | Open Market | 2,500 | $5K | 5/20/2025 | View on chart |
| PHIO | ▲ Buy | Grant | 10,000 | $0 | 9/11/2024 | View on chart |
| PHIO | ▲ Buy | Open Market | 2,000 | $6K | 6/14/2023 | View on chart |
| PHIO | ▲ Buy | Grant | 1,500 | $0 | 2/17/2023 | View on chart |
| PHIO | ▲ Buy | Open Market | 5,000 | $2K | 12/2/2022 | View on chart |
| PHIO | ▲ Buy | Open Market | 2,000 | $820 | 11/23/2022 | View on chart |
| PHIO | ▲ Buy | Grant | 10,000 | $0 | 2/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
PHIO to Speak at NIBA Conference as OTC Markets Announces Forum
Phio Pharmaceuticals will present at the National Investment Banking Association’s 153rd conference. The presentation gives the company a chance to share updates with investors. At the same time, OTC Markets Group released the agenda for its third annual Global Markets Forum, an event that could influence activity on the OTC market where PHIO trades.
PHIO to Speak at NIBA Conference as OTC Markets Announces Forum. Phio Pharmaceuticals will present at the National Investment Banking Association’s 153rd conference. The presentation gives the company a chance to share updates with investors. At the same time, OTC Markets Group released the agenda for its third annual Global Markets Forum, an event that could influence activity on the OTC market where PHIO trades.